Latest On Global Blood Therapeutics, Inc (GBT):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-09-30 17:28 EST | News | Global Blood Therapeutics expects to complete Pfizer deal in early October | N/A |  |
| 2022-09-17 03:45 EST | News | Global Blood Therapeutics: Pfizer Acquisition Signals Increasing M/A Deals | N/A | |
| 2022-08-24 20:51 EST | News | Pfizer said to have had bidding war with Johnson & Johnson for Global Blood | N/A | |
| 2022-08-10 17:00 EST | News | Global Blood Therapeutics GAAP EPS of -$1.26 misses by $0.08, revenue of $71.55M beats by $7.16M | N/A | |
| 2022-08-09 02:46 EST | News | What Pfizer Is Getting Through The Acquisition Of Global Blood Therapeutics | N/A | |
| 2022-08-05 18:31 EST | News | Pfizer in 'advanced talks' to buy Global Blood Therapeutics in ~$5B deal - WSJ | N/A | |
| 2022-08-04 11:21 EST | News | Global Blood Therapeutics up 18% after report on buyout interest | N/A | |
| 2022-07-14 22:55 EST | News | Global Blood Therapeutics to expand access to its sickle cell disease treatment in Brazil | N/A | |
| 2022-06-29 17:05 EST | News | GBT begins phase 2/3 clinical trial of GBT601 to treat sickle cell disease | N/A | |
| 2022-06-22 02:40 EST | News | Global Blood Therapeutics: Powerhouse Of The Future | N/A | |
| 2022-06-19 19:33 EST | News | Global Blood Therapeutics (GBT) Presents at the William Blair 42nd Annual Growth Stock Conference - Slideshow | N/A | |
| 2022-06-06 20:56 EST | News | Global Blood Therapeutics nabs FDA designations for sickle cell disease therapy | N/A | |
| 2022-05-15 12:43 EST | News | Global Blood, Impel Pharma could be M&A targets after Biohaven deal - analysts | N/A | |
| 2022-05-07 02:20 EST | News | Global Blood Therapeutics (GBT) Investor Presentation - Slideshow | N/A | |
| 2022-05-05 03:37 EST | News | Global Blood Therapeutics GAAP EPS of -$1.26 beats by $0.06, revenue of $55.16M misses by $0.97M | N/A | |
| 2022-05-05 03:37 EST | News | Global Blood Therapeutics Inc. (GBT) CEO Ted Love on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-04 06:50 EST | News | Global Blood Therapeutics Q1 2022 Earnings Preview | N/A | |
| 2022-04-13 03:09 EST | News | Global Blood Therapeutics: Hitting A Growth Inflection | N/A | |
| 2022-03-12 06:07 EST | News | Global Blood Therapeutics: Changing My Strategy After Recent Earnings | N/A | |
| 2022-02-24 12:42 EST | News | Global Blood Therapeutics, Inc. (GBT) CEO Ted Love on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-23 17:12 EST | News | Global Blood Therapeutics GAAP EPS of -$1.36 misses by $0.23, revenue of $56.1M beats by $0.65M | N/A | |
| 2022-02-23 00:38 EST | News | Global Blood Therapeutics Q4 2021 Earnings Preview | N/A | |
| 2022-02-16 20:01 EST | News | Global Blood Therapeutics Oxbryta for sickle cell disease gets approval in EU | N/A | |
| 2022-01-14 08:15 EST | News | Global Blood Therapeutics price target lowered at Cantor on COVID headwinds for Oxbryta | N/A | |
| 2022-01-12 04:47 EST | News | Global Blood Therapeutics (GBT) Presents At 40th Annual J.P. Morgan Healthcare Conference - Slideshow | N/A | |
| 2021-12-25 23:24 EST | News | Global Blood Therapeutics: Revisiting A Stellar Grower | N/A | |
| 2021-12-17 23:03 EST | News | Global Blood Therapeutics wins EU backing for sickle cell disease therapy | N/A | |
| 2021-12-17 23:02 EST | News | Global Blood Therapeutics granted FDA label expansion for sickle cell disease therapy | N/A | |
| 2021-12-16 07:06 EST | News | Global Blood Therapeutics up 8% following upsized $300M private offering | N/A | |
| 2021-12-15 11:20 EST | News | Global Blood Therapeutics prices upsized $300M of notes offering | N/A | |
| 2021-12-14 14:47 EST | News | GBT slumps after announcing offering of $250.0M in convertible senior notes | N/A | |
| 2021-12-13 20:01 EST | News | Global Blood Therapeutics (GBT) presents at ASH Annual Meeting - Slideshow | N/A | |
| 2021-12-08 06:39 EST | News | Global Blood Therapeutics (GBT) GBT 2021 R&D Day | N/A | |
| 2021-12-01 01:46 EST | News | IBI Research On Global Blood Therapeutics: Galvanized For Growth | N/A | |
| 2021-11-10 08:21 EST | News | Warning: GBT is at high risk of performing badly | N/A | |
| 2021-11-05 06:19 EST | News | Global Blood Therapeutics EPS misses by $0.02, misses on revenue | N/A | |
| 2021-11-05 06:18 EST | News | Global Blood Therapeutics, Inc. (GBT) CEO Ted Love on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-04 09:24 EST | News | Global Blood Therapeutics Q3 2021 Earnings Preview | N/A | |
| 2021-10-24 21:24 EST | News | Global Blood Therapeutics: It Might Be Time To Buy The Dip | N/A | |
| 2021-10-08 07:56 EST | News | Global Blood Therapeutics up on Jefferies buy initiation; sees ~145% upside | N/A | |
| 2021-09-10 21:29 EST | News | Global Blood Therapeutics (GBT) Corporate Presentation | N/A | |
| 2021-09-07 13:42 EST | News | FDA accepts for review Global Blood Therapeutics sNDA for Oxbryta in sickle cell disease | N/A | |
| 2021-08-07 18:38 EST | News | Global Blood Therapeutics: Attempting To Classify The Investment | N/A | |
| 2021-08-06 03:18 EST | News | Global Blood Therapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-08-05 05:04 EST | News | Truist upgrades Global Blood Therapeutics to buy on Q2 2021 results; shares up 17% | N/A | |
| 2021-08-04 07:32 EST | News | Global Blood Therapeutics EPS beats by $0.07, beats on revenue | N/A | |
| 2021-08-04 07:32 EST | News | Global Blood Therapeutics, Inc. (GBT) CEO Ted Love on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-03 11:44 EST | News | Global Blood Therapeutics Q2 2021 Earnings Preview | N/A | |
| 2021-07-21 09:35 EST | News | Global Blood Therapeutics announces employment inducement grants | N/A | |
| 2021-07-21 09:25 EST | News | Intellia in focus after landmark trial data, Unity Biotech wins double upgrade: in today's analyst action | N/A | |
About Global Blood Therapeutics, Inc (GBT):
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities. The company offers Oxbryta tablets, an oral, once-daily therapy for sickle cell disease (SCD). It is evaluating the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase 2a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing inclacumab, a novel human monoclonal antibody to treat vaso-occlusive crises; and GBT601, a hemoglobin polymerization inhibitor. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD) and beta thalassemia. The company was founded in 2011 and is headquartered in South San Francisco, California.
General
- Name Global Blood Therapeutics, Inc
- Symbol GBT
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 389
- Fiscal Year EndDecember
- IPO Date2015-08-12
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.gbt.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 21.1
- Price/Book (Most Recent Quarter) 6.36
- Enterprise Value Revenue 18.74
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$3.78
- Next Year EPS Estimate -$2.15
- Next Quarter EPS Estimate -$0.95
- Profit Margin -200%
- Operating Margin -197%
- Return on Assets -20%
- Return on Equity -50%
- Revenue 123.8 million
- Earnings Per Share -$3.65
- Revenue Per Share $2.02
- Gross Profit 121.82 million
- Quarterly Earnings Growth 1859%
View More
Highlights
- Market Capitalization 2.74 billion
- EBITDA -209132992
- PEG Ratio -0.3
- Analyst Target Price $83.75
- Book Value Per Share $6.72
View More
Share Statistics
- Shares Outstanding 62.16 million
- Shares Float 54.97 million
- % Held by Insiders 177%
- % Held by Institutions 108.4%
- Shares Short 11.86 million
- Shares Short Prior Month 11.54 million
- Short Ratio 10.2
- Short % of Float 22%
- Short % of Shares Outstanding 19%
View More
Technicals
- Beta 1.1
- 52 Week High $83.69
- 52 Week Low $36.49
- 50 Day Moving Average 46.51
- 200 Day Moving Average 49.48
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Global Blood Therapeutics, Inc (GBT) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Global Blood Therapeutics, Inc (GBT) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-24 | $N/A | -$1.02 | -$0.97 | -5% |
| 2020-09-30 | 2020-11-05 | $N/A | -$0.97 | -$0.69 | -41.5% |
| 2020-06-30 | 2020-08-05 | $31.5 million | -$0.86 | -$1.14 | 24.8% |
| 2020-03-31 | 2020-05-06 | $N/A | -$1.20 | -$1.55 | 22.75% |
| 2019-12-31 | 2020-02-26 | $2.11 million | -$1.73 | -$1.23 | -40.47% |
| 2019-09-30 | 2019-11-07 | $N/A | -$1.07 | -$1.05 | -1.52% |
| 2019-06-30 | 2019-08-07 | $N/A | -$1.01 | -$0.96 | -5.63% |
| 2019-03-31 | 2019-05-08 | $N/A | -$0.87 | -$0.96 | 9.55% |
| 2018-12-31 | 2019-02-27 | $N/A | -$0.93 | -$0.89 | -4.94% |
| 2018-09-30 | 2018-11-06 | $N/A | -$0.83 | -$0.85 | 2.42% |
| 2018-06-30 | 2018-08-02 | $N/A | -$0.78 | -$0.87 | 10.76% |
| 2018-03-31 | 2018-05-07 | $N/A | -$0.87 | -$0.91 | 4.05% |
| 2017-12-31 | 2018-02-27 | $N/A | -$0.94 | -$0.72 | -31.1% |
| 2017-09-30 | 2017-11-02 | $N/A | -$0.66 | -$0.62 | -7.09% |
| 2017-06-30 | 2017-08-07 | $N/A | -$0.55 | -$0.61 | 9.11% |
| 2017-03-31 | 2017-05-01 | $N/A | -$0.60 | -$0.71 | 15.78% |
| 2016-12-31 | 2017-03-13 | $N/A | -$0.74 | -$0.64 | -16.1% |
| 2016-09-30 | 2016-11-09 | $N/A | -$0.58 | -$0.59 | 2.36% |
| 2016-06-30 | 2016-08-10 | $N/A | -$0.58 | -$0.63 | 8.42% |
| 2016-03-31 | 2016-05-12 | $N/A | -$0.56 | -$0.48 | -15.87% |
| 2015-12-31 | 2016-03-29 | $N/A | -$0.53 | -$0.43 | -23.26% |
| 2015-09-30 | 2015-11-12 | $N/A | -$0.90 | -$0.59 | -52.54% |
| 2015-06-30 | 2015-08-17 | $N/A | -$4.84 | -$2.39 | -102.51% |
Global Blood Therapeutics, Inc (GBT) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Global Blood Therapeutics, Inc (GBT) Chart:
Global Blood Therapeutics, Inc (GBT) News:
Below you will find a list of latest news for Global Blood Therapeutics, Inc (GBT) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Global Blood Therapeutics, Inc (GBT) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-01-17 | 45 | 0 | CALL | 0 | TRUE | 0 | 0 | ||
| 2025-01-17 | 50 | 0 | CALL | 0 | TRUE | 0 | 0 | ||
| 2025-01-17 | 55 | 0 | CALL | 0 | TRUE | 0 | 0 | ||
| 2025-01-17 | 60 | 0 | CALL | 0 | TRUE | 0 | 0 | ||
| 2025-01-17 | 65 | 0 | CALL | 0 | TRUE | 0 | 0 | ||
| 2025-01-17 | 67.5 | 1.05 | CALL | 6 | 11 | 0 | TRUE | -0.25 | -0.19 |
| 2025-01-17 | 70 | 0.05 | CALL | 15 | 0 | FALSE | 0.05 | 0 | |
| 2025-01-17 | 75 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2025-01-17 | 80 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2025-01-17 | 85 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2025-01-17 | 90 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2025-01-17 | 95 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2025-01-17 | 45 | 0 | PUT | 0 | FALSE | 0 | 0 | ||
| 2025-01-17 | 50 | 0 | PUT | 0 | FALSE | 0 | 0 | ||
| 2025-01-17 | 55 | 0 | PUT | 0 | FALSE | 0 | 0 | ||
| 2025-01-17 | 60 | 0 | PUT | 0 | FALSE | 0 | 0 | ||
| 2025-01-17 | 65 | 0 | PUT | 0 | FALSE | 0 | 0 | ||
| 2025-01-17 | 67.5 | 0.05 | PUT | 2 | 811 | 2.79 | FALSE | 0 | 0 |
| 2025-01-17 | 70 | 0 | PUT | 8.8 | TRUE | 0 | 0 | ||
| 2025-01-17 | 75 | 0 | PUT | 11.14 | TRUE | 0 | 0 | ||
| 2025-01-17 | 80 | 0 | PUT | 17.59 | TRUE | 0 | 0 | ||
| 2025-01-17 | 85 | 0 | PUT | 21.25 | TRUE | 0 | 0 | ||
| 2025-01-17 | 90 | 0 | PUT | 23.87 | TRUE | 0 | 0 | ||
| 2025-01-17 | 95 | 0 | PUT | 26.8 | TRUE | 0 | 0 |
Latest GBT Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 24 | $22.55 |
| Jun 13, 2022 7:59 PM EST | 100 | $22.55 |
| Jun 13, 2022 7:59 PM EST | 1 | $22.545 |
| Jun 13, 2022 7:59 PM EST | 83 | $22.545 |
| Jun 13, 2022 7:59 PM EST | 19 | $22.55 |
Global Blood Therapeutics, Inc (GBT) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000120919120039333/0001209191-20-039333-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000008025519002709/0000080255-19-002709-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000008025520001305/0000080255-20-001305-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000021545719003998/0000215457-19-003998-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000031506619001089/0000315066-19-001089-index.htm |
| 2019-11-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000031506619001768/0000315066-19-001768-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000031506620000958/0000315066-20-000958-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000031506620001327/0000315066-20-001327-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000083423720005274/0000834237-20-005274-index.htm |
| 2018-12-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924318031623/0000899243-18-031623-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924318031625/0000899243-18-031625-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319002662/0000899243-19-002662-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319002665/0000899243-19-002665-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319002666/0000899243-19-002666-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319002667/0000899243-19-002667-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319002668/0000899243-19-002668-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319002670/0000899243-19-002670-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319003656/0000899243-19-003656-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319003657/0000899243-19-003657-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319003661/0000899243-19-003661-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319003662/0000899243-19-003662-index.htm |
| 2019-03-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319006304/0000899243-19-006304-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319006307/0000899243-19-006307-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319006308/0000899243-19-006308-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319009557/0000899243-19-009557-index.htm |
| 2019-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319010470/0000899243-19-010470-index.htm |
| 2019-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319010471/0000899243-19-010471-index.htm |
| 2019-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319010472/0000899243-19-010472-index.htm |
| 2019-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319010474/0000899243-19-010474-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319017612/0000899243-19-017612-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319017614/0000899243-19-017614-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319017615/0000899243-19-017615-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319017616/0000899243-19-017616-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319017617/0000899243-19-017617-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319017618/0000899243-19-017618-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319017619/0000899243-19-017619-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319017620/0000899243-19-017620-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021012/0000899243-19-021012-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021013/0000899243-19-021013-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021017/0000899243-19-021017-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021018/0000899243-19-021018-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021019/0000899243-19-021019-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021021/0000899243-19-021021-index.htm |
| 2019-08-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021574/0000899243-19-021574-index.htm |
| 2019-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319022721/0000899243-19-022721-index.htm |
| 2019-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319022728/0000899243-19-022728-index.htm |
| 2019-09-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319023567/0000899243-19-023567-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319024769/0000899243-19-024769-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319024773/0000899243-19-024773-index.htm |
| 2019-10-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319024978/0000899243-19-024978-index.htm |
| 2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319024981/0000899243-19-024981-index.htm |
| 2019-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319025423/0000899243-19-025423-index.htm |
| 2019-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319026672/0000899243-19-026672-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/0000899243-19-027545-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027721/0000899243-19-027721-index.htm |
| 2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/0000899243-19-028243-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028411/0000899243-19-028411-index.htm |
| 2019-12-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028797/0000899243-19-028797-index.htm |
| 2019-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028940/0000899243-19-028940-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029172/0000899243-19-029172-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029487/0000899243-19-029487-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029489/0000899243-19-029489-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029490/0000899243-19-029490-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029493/0000899243-19-029493-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029494/0000899243-19-029494-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320000363/0000899243-20-000363-index.htm |
| 2020-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320001815/0000899243-20-001815-index.htm |
| 2020-01-29 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320002291/0000899243-20-002291-index.htm |
| 2020-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320002292/0000899243-20-002292-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320002967/0000899243-20-002967-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320002973/0000899243-20-002973-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003025/0000899243-20-003025-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003027/0000899243-20-003027-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003031/0000899243-20-003031-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/0000899243-20-003032-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003040/0000899243-20-003040-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003043/0000899243-20-003043-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003048/0000899243-20-003048-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003859/0000899243-20-003859-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320005344/0000899243-20-005344-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320005350/0000899243-20-005350-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320007085/0000899243-20-007085-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320007086/0000899243-20-007086-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320007087/0000899243-20-007087-index.htm |
| 2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320007676/0000899243-20-007676-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320008652/0000899243-20-008652-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320010117/0000899243-20-010117-index.htm |
| 2020-04-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320011153/0000899243-20-011153-index.htm |
| 2020-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320011549/0000899243-20-011549-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013017/0000899243-20-013017-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013018/0000899243-20-013018-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013683/0000899243-20-013683-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320014410/0000899243-20-014410-index.htm |
| 2020-06-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320014727/0000899243-20-014727-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320014729/0000899243-20-014729-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320015149/0000899243-20-015149-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320015151/0000899243-20-015151-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320015152/0000899243-20-015152-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320015153/0000899243-20-015153-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320015157/0000899243-20-015157-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320015158/0000899243-20-015158-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320015159/0000899243-20-015159-index.htm |
| 2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320016154/0000899243-20-016154-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017305/0000899243-20-017305-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017307/0000899243-20-017307-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017308/0000899243-20-017308-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017311/0000899243-20-017311-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017314/0000899243-20-017314-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017315/0000899243-20-017315-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017317/0000899243-20-017317-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017318/0000899243-20-017318-index.htm |
| 2020-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320019186/0000899243-20-019186-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021321/0000899243-20-021321-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021323/0000899243-20-021323-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021325/0000899243-20-021325-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021329/0000899243-20-021329-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021330/0000899243-20-021330-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021331/0000899243-20-021331-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021333/0000899243-20-021333-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021756/0000899243-20-021756-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320023299/0000899243-20-023299-index.htm |
| 2020-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320024183/0000899243-20-024183-index.htm |
| 2020-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320024184/0000899243-20-024184-index.htm |
| 2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320025019/0000899243-20-025019-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320027383/0000899243-20-027383-index.htm |
| 2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000089924320027726/0000899243-20-027726-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000090221919000163/0000902219-19-000163-index.htm |
| 2020-01-28 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000090221920000305/0000902219-20-000305-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000093247119005044/0000932471-19-005044-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000110465920017929/0001104659-20-017929-index.htm |
| 2018-12-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184318008533/0001171843-18-008533-index.htm |
| 2019-01-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319000573/0001171843-19-000573-index.htm |
| 2019-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319001274/0001171843-19-001274-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319003118/0001171843-19-003118-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319003994/0001171843-19-003994-index.htm |
| 2019-06-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319004086/0001171843-19-004086-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319005255/0001171843-19-005255-index.htm |
| 2019-09-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319005815/0001171843-19-005815-index.htm |
| 2019-10-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319006621/0001171843-19-006621-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319007216/0001171843-19-007216-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319007326/0001171843-19-007326-index.htm |
| 2019-11-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319007745/0001171843-19-007745-index.htm |
| 2019-11-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319007820/0001171843-19-007820-index.htm |
| 2019-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319008194/0001171843-19-008194-index.htm |
| 2019-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184319008195/0001171843-19-008195-index.htm |
| 2020-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184320000129/0001171843-20-000129-index.htm |
| 2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184320001282/0001171843-20-001282-index.htm |
| 2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184320001442/0001171843-20-001442-index.htm |
| 2020-03-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184320001796/0001171843-20-001796-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184320003374/0001171843-20-003374-index.htm |
| 2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184320004102/0001171843-20-004102-index.htm |
| 2020-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184320004247/0001171843-20-004247-index.htm |
| 2020-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184320004453/0001171843-20-004453-index.htm |
| 2020-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184320004519/0001171843-20-004519-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184320005549/0001171843-20-005549-index.htm |
| 2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184320007223/0001171843-20-007223-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184320007562/0001171843-20-007562-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000117184320007668/0001171843-20-007668-index.htm |
| 2018-12-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1629137/000119312518346638/0001193125-18-346638-index.htm |
| 2018-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000119312518347766/0001193125-18-347766-index.htm |
| 2019-01-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1629137/000119312519018825/0001193125-19-018825-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000119312519040908/0001193125-19-040908-index.htm |
| 2019-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1629137/000119312519054260/0001193125-19-054260-index.htm |
| 2019-03-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000119312519088438/0001193125-19-088438-index.htm |
| 2019-03-29 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1629137/000119312519092633/0001193125-19-092633-index.htm |
| 2019-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1629137/000119312519125149/0001193125-19-125149-index.htm |
| 2019-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1629137/000119312519125166/0001193125-19-125166-index.htm |
| 2019-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1629137/000119312519125183/0001193125-19-125183-index.htm |
| 2019-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1629137/000119312519143371/0001193125-19-143371-index.htm |
| 2019-06-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1629137/000119312519181246/0001193125-19-181246-index.htm |
| 2019-06-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1629137/000119312519185093/0001193125-19-185093-index.htm |
| 2019-06-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1629137/000119312519185973/0001193125-19-185973-index.htm |
| 2019-06-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000119312519185985/0001193125-19-185985-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1629137/000119312519215331/0001193125-19-215331-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1629137/000119312519287292/0001193125-19-287292-index.htm |
| 2020-01-23 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1629137/000119312520013118/0001193125-20-013118-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000119312520038150/0001193125-20-038150-index.htm |
| 2020-02-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1629137/000119312520050084/0001193125-20-050084-index.htm |
| 2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1629137/000119312520122993/0001193125-20-122993-index.htm |
| 2020-04-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1629137/000119312520123001/0001193125-20-123001-index.htm |
| 2020-04-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1629137/000119312520123006/0001193125-20-123006-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1629137/000119312520134894/0001193125-20-134894-index.htm |
| 2020-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1629137/000119312520143935/0001193125-20-143935-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1629137/000119312520210626/0001193125-20-210626-index.htm |
| 2020-08-05 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1629137/000119312520210802/0001193125-20-210802-index.htm |
| 2020-08-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1629137/000119312520213059/0001193125-20-213059-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1629137/000119312520286837/0001193125-20-286837-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1629137/000120919120039333/0001209191-20-039333-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000127417319000019/0001274173-19-000019-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000127417319000030/0001274173-19-000030-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1629137/000156761920003780/0001567619-20-003780-index.htm |
| 2019-03-07 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1629137/999999999719000810/9999999997-19-000810-index.htm |
Global Blood Therapeutics, Inc (GBT) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Global Blood Therapeutics, Inc (GBT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 177%Institutional Ownership: 10840%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-10-08 | DEVAL L PATRICK | Director | Sell | 5,357.00 | 45.05 | 241,332.85 | 0.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319025423/0000899243-19-025423-index.htm |
| 2020-08-05 | Eric Fink | Chief Human Resources Officer | Sell | 950.00 | 70.10 | 66,595.76 | 0.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021756/0000899243-20-021756-index.htm |
| 2020-10-05 | Eric Fink | Chief Human Resources Officer | Sell | 4,532.00 | 60.00 | 271,920.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320027726/0000899243-20-027726-index.htm |
| 2019-11-14 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 329.00 | 50.01 | 16,454.51 | 0.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/0000899243-19-027545-index.htm |
| 2019-11-15 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 9,948.00 | 50.00 | 497,446.76 | 0.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/0000899243-19-027545-index.htm |
| 2019-11-18 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 656.00 | 50.63 | 33,213.28 | 0.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027721/0000899243-19-027721-index.htm |
| 2019-11-19 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 6,562.00 | 55.00 | 360,910.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027721/0000899243-19-027721-index.htm |
| 2019-11-25 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 312.00 | 60.00 | 18,720.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/0000899243-19-028243-index.htm |
| 2019-11-26 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 11,593.00 | 67.19 | 778,933.67 | 0.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/0000899243-19-028243-index.htm |
| 2019-12-09 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 937.00 | 78.50 | 73,554.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028940/0000899243-19-028940-index.htm |
| 2019-12-11 | Philip A. Pizzo | Director | Sell | 2,132.00 | 77.25 | 164,698.49 | 0.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029172/0000899243-19-029172-index.htm |
| 2019-11-01 | TRICIA BORGA SUVARI | Chief Legal Officer | Sell | 2,200.00 | 48.33 | 106,334.36 | 10,186.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319026672/0000899243-19-026672-index.htm |
| 2019-02-12 | Lesley Ann Calhoun | Officer | Sell | 354.00 | 50.45 | 17,860.36 | 1,032.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319003661/0000899243-19-003661-index.htm |
| 2020-04-28 | TED W LOVE | Officer | Sell | 40,000.00 | 80.00 | 3,200,160.00 | 1,034,633.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320011549/0000899243-20-011549-index.htm |
| 2020-01-22 | TED W LOVE | Officer | Sell | 1,031.00 | 82.45 | 85,011.00 | 1,061,984.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320001815/0000899243-20-001815-index.htm |
| 2020-01-31 | TED W LOVE | Officer | Buy | 579.00 | 36.68 | 21,237.72 | 1,062,563.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003043/0000899243-20-003043-index.htm |
| 2020-01-22 | TED W LOVE | Officer | Sell | 32,150.00 | 81.85 | 2,631,599.67 | 1,063,015.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320001815/0000899243-20-001815-index.htm |
| 2020-04-27 | TED W LOVE | Officer | Sell | 1,517.00 | 80.63 | 122,319.81 | 1,074,633.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320011549/0000899243-20-011549-index.htm |
| 2020-04-27 | TED W LOVE | Officer | Sell | 1,300.00 | 81.15 | 105,493.96 | 1,076,150.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320011549/0000899243-20-011549-index.htm |
| 2020-02-18 | TED W LOVE | Officer | Sell | 1,818.00 | 70.92 | 128,939.65 | 1,077,450.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320005344/0000899243-20-005344-index.htm |
| 2020-02-18 | TED W LOVE | Officer | Sell | 2,189.00 | 70.22 | 153,720.77 | 1,079,268.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320005344/0000899243-20-005344-index.htm |
| 2020-01-22 | TED W LOVE | Officer | Sell | 6,819.00 | 81.01 | 552,435.83 | 1,095,165.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320001815/0000899243-20-001815-index.htm |
| 2020-02-01 | TED W LOVE | Officer | Buy | 33,063.00 | 1,095,626.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003043/0000899243-20-003043-index.htm | ||
| 2019-12-06 | TED W LOVE | Officer | Sell | 3,716.00 | 76.15 | 282,973.40 | 1,097,867.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028797/0000899243-19-028797-index.htm |
| 2019-12-06 | TED W LOVE | Officer | Sell | 23,152.00 | 77.72 | 1,799,327.14 | 1,101,583.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028797/0000899243-19-028797-index.htm |
| 2020-01-21 | TED W LOVE | Officer | Sell | 523.00 | 83.56 | 43,702.66 | 1,101,984.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320001815/0000899243-20-001815-index.htm |
| 2019-01-31 | TRICIA BORGA SUVARI | Chief Legal Officer | Buy | 318.00 | 36.68 | 11,664.24 | 11,022.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319010470/0000899243-19-010470-index.htm |
| 2020-01-21 | TED W LOVE | Officer | Sell | 10,166.00 | 82.78 | 841,561.81 | 1,102,507.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320001815/0000899243-20-001815-index.htm |
| 2019-11-25 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 1,108.00 | 19.89 | 22,038.12 | 1,108.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/0000899243-19-028243-index.htm |
| 2020-01-21 | TED W LOVE | Officer | Sell | 29,311.00 | 81.98 | 2,402,836.64 | 1,112,673.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320001815/0000899243-20-001815-index.htm |
| 2020-01-31 | DAVID LEE JOHNSON | Chief Commercial Officer | Buy | 310.00 | 36.68 | 11,370.80 | 11,227.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003027/0000899243-20-003027-index.htm |
| 2019-12-06 | TED W LOVE | Officer | Sell | 6,800.00 | 76.78 | 522,121.68 | 1,124,735.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028797/0000899243-19-028797-index.htm |
| 2019-12-06 | TED W LOVE | Officer | Sell | 6,332.00 | 75.73 | 479,511.60 | 1,131,535.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028797/0000899243-19-028797-index.htm |
| 2019-12-05 | TED W LOVE | Officer | Sell | 6,750.00 | 75.39 | 508,873.05 | 1,137,867.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028797/0000899243-19-028797-index.htm |
| 2019-01-31 | TED W LOVE | Officer | Buy | 579.00 | 36.68 | 21,237.72 | 1,143,553.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319010474/0000899243-19-010474-index.htm |
| 2019-12-05 | TED W LOVE | Officer | Sell | 8,525.00 | 74.66 | 636,478.21 | 1,144,617.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028797/0000899243-19-028797-index.htm |
| 2019-02-01 | TED W LOVE | Officer | Buy | 21,813.00 | 1,150,788.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319002666/0000899243-19-002666-index.htm | ||
| 2020-02-03 | TRICIA BORGA SUVARI | Chief Legal Officer | Sell | 1,308.00 | 62.81 | 82,155.48 | 11,521.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003025/0000899243-20-003025-index.htm |
| 2019-02-01 | TRICIA BORGA SUVARI | Chief Legal Officer | Buy | 3,250.00 | 11,526.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319002665/0000899243-19-002665-index.htm | ||
| 2019-12-05 | TED W LOVE | Officer | Sell | 996.00 | 74.08 | 73,783.68 | 1,153,142.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028797/0000899243-19-028797-index.htm |
| 2019-12-05 | TED W LOVE | Officer | Sell | 12,442.00 | 75.35 | 937,474.84 | 1,154,138.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028797/0000899243-19-028797-index.htm |
| 2019-11-26 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 11,593.00 | 59.60 | 690,942.80 | 11,593.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/0000899243-19-028243-index.htm |
| 2019-12-05 | TED W LOVE | Officer | Sell | 11,287.00 | 74.62 | 842,261.90 | 1,166,580.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028797/0000899243-19-028797-index.htm |
| 2019-12-13 | TRICIA BORGA SUVARI | Chief Legal Officer | Buy | 5,000.00 | 11,752.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029489/0000899243-19-029489-index.htm | ||
| 2019-04-08 | TED W LOVE | Officer | Buy | 35,000.00 | 1,178,553.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319010474/0000899243-19-010474-index.htm | ||
| 2019-12-13 | TED W LOVE | Officer | Buy | 87,500.00 | 1,185,367.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029494/0000899243-19-029494-index.htm | ||
| 2019-08-01 | TED W LOVE | Officer | Buy | 33,062.00 | 1,194,261.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021021/0000899243-19-021021-index.htm | ||
| 2019-11-01 | TRICIA BORGA SUVARI | Chief Legal Officer | Sell | 1,127.00 | 48.68 | 54,857.29 | 12,386.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319026672/0000899243-19-026672-index.htm |
| 2019-10-01 | DAVID LEE JOHNSON | Chief Commercial Officer | Buy | 4,375.00 | 12,454.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319024773/0000899243-19-024773-index.htm | ||
| 2019-07-31 | TRICIA BORGA SUVARI | Chief Legal Officer | Buy | 262.00 | 36.68 | 9,610.16 | 12,592.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021019/0000899243-19-021019-index.htm |
| 2019-04-08 | TRICIA BORGA SUVARI | Chief Legal Officer | Buy | 2,000.00 | 13,022.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319010470/0000899243-19-010470-index.htm | ||
| 2019-03-01 | Lesley Ann Calhoun | Officer | Buy | 300.00 | 1,332.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319006308/0000899243-19-006308-index.htm | ||
| 2019-10-01 | TRICIA BORGA SUVARI | Chief Legal Officer | Sell | 3,249.00 | 48.70 | 158,226.30 | 13,513.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319024769/0000899243-19-024769-index.htm |
| 2019-01-31 | Lesley Ann Calhoun | Officer | Buy | 354.00 | 36.68 | 12,984.72 | 1,386.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319003661/0000899243-19-003661-index.htm |
| 2019-11-15 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 1,109.00 | 19.89 | 22,058.01 | 1,422.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/0000899243-19-027545-index.htm |
| 2020-01-31 | Lesley Ann Calhoun | Officer | Buy | 535.00 | 36.68 | 19,623.80 | 1,422.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003048/0000899243-20-003048-index.htm |
| 2020-02-01 | DAVID LEE JOHNSON | Chief Commercial Officer | Buy | 3,125.00 | 14,352.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003027/0000899243-20-003027-index.htm | ||
| 2019-01-31 | Jung Choi | Officer | Buy | 269.00 | 36.68 | 9,866.92 | 144,543.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319010472/0000899243-19-010472-index.htm |
| 2019-07-31 | Lesley Ann Calhoun | Officer | Buy | 226.00 | 36.68 | 8,289.68 | 1,454.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021013/0000899243-19-021013-index.htm |
| 2019-07-31 | Jung Choi | Officer | Buy | 285.00 | 36.68 | 10,453.80 | 146,136.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021018/0000899243-19-021018-index.htm |
| 2019-02-01 | Jung Choi | Officer | Buy | 6,938.00 | 146,512.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319002668/0000899243-19-002668-index.htm | ||
| 2019-04-08 | Jung Choi | Officer | Buy | 2,000.00 | 146,543.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319010472/0000899243-19-010472-index.htm | ||
| 2019-12-11 | Philip A. Pizzo | Director | Buy | 15,000.00 | 18.85 | 282,750.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029172/0000899243-19-029172-index.htm |
| 2020-02-01 | TRICIA BORGA SUVARI | Chief Legal Officer | Buy | 6,375.00 | 15,124.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003025/0000899243-20-003025-index.htm | ||
| 2020-08-01 | Jeffrey S Farrow | Chief Financial Officer | Buy | 12,082.00 | 15,130.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021323/0000899243-20-021323-index.htm | ||
| 2020-05-12 | Lesley Ann Calhoun | Officer | Sell | 2,992.00 | 78.38 | 234,512.36 | 154.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013018/0000899243-20-013018-index.htm |
| 2020-05-18 | Lesley Ann Calhoun | Officer | Sell | 23,330.00 | 74.67 | 1,742,051.10 | 154.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013683/0000899243-20-013683-index.htm |
| 2020-05-26 | Lesley Ann Calhoun | Officer | Sell | 2,700.00 | 70.10 | 189,270.00 | 154.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320014410/0000899243-20-014410-index.htm |
| 2020-01-31 | Jung Choi | Officer | Buy | 286.00 | 36.68 | 10,490.48 | 155,015.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003031/0000899243-20-003031-index.htm |
| 2019-08-01 | Jung Choi | Officer | Buy | 10,062.00 | 156,198.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021018/0000899243-19-021018-index.htm | ||
| 2019-12-13 | Jung Choi | Officer | Buy | 5,000.00 | 157,208.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029490/0000899243-19-029490-index.htm | ||
| 2020-07-31 | Jung Choi | Officer | Buy | 162.00 | 36.68 | 5,942.16 | 161,670.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021321/0000899243-20-021321-index.htm |
| 2020-07-31 | DAVID LEE JOHNSON | Chief Commercial Officer | Buy | 316.00 | 36.68 | 11,590.88 | 16,363.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021330/0000899243-20-021330-index.htm |
| 2020-02-01 | Jung Choi | Officer | Buy | 10,063.00 | 165,078.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003031/0000899243-20-003031-index.htm | ||
| 2020-08-01 | TRICIA BORGA SUVARI | Chief Legal Officer | Buy | 9,395.00 | 17,084.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021331/0000899243-20-021331-index.htm | ||
| 2020-08-01 | Jung Choi | Officer | Buy | 13,082.00 | 174,752.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021321/0000899243-20-021321-index.htm | ||
| 2020-04-01 | DAVID LEE JOHNSON | Chief Commercial Officer | Buy | 4,375.00 | 17,560.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320010117/0000899243-20-010117-index.htm | ||
| 2019-02-01 | Lesley Ann Calhoun | Officer | Buy | 750.00 | 1,784.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319002667/0000899243-19-002667-index.htm | ||
| 2020-06-09 | Jeffrey S Farrow | Chief Financial Officer | Sell | 15,208.00 | 67.00 | 1,018,936.00 | 18,256.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320016154/0000899243-20-016154-index.htm |
| 2019-08-01 | TRICIA BORGA SUVARI | Chief Legal Officer | Buy | 6,375.00 | 18,967.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021019/0000899243-19-021019-index.htm | ||
| 2020-09-10 | GLENN PIERCE | Director | Buy | 15,000.00 | 15.03 | 225,450.00 | 19,800.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320025019/0000899243-20-025019-index.htm |
| 2020-01-27 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 781.00 | 71.15 | 55,568.15 | 2,016.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320002292/0000899243-20-002292-index.htm |
| 2019-12-11 | Philip A. Pizzo | Director | Sell | 27,868.00 | 76.52 | 2,132,529.03 | 2,132.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029172/0000899243-19-029172-index.htm |
| 2019-04-08 | Jeffrey S Farrow | Chief Financial Officer | Buy | 2,000.00 | 21,329.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319010471/0000899243-19-010471-index.htm | ||
| 2019-02-01 | Jeffrey S Farrow | Chief Financial Officer | Buy | 5,938.00 | 21,493.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319002662/0000899243-19-002662-index.htm | ||
| 2020-06-19 | Dawn Svoronos | Director | Sell | 881.00 | 64.42 | 56,749.97 | 2,256.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017315/0000899243-20-017315-index.htm |
| 2020-08-01 | DAVID LEE JOHNSON | Chief Commercial Officer | Buy | 6,770.00 | 23,133.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021330/0000899243-20-021330-index.htm | ||
| 2020-05-18 | Lesley Ann Calhoun | Officer | Buy | 23,330.00 | 22.00 | 513,260.00 | 23,484.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013683/0000899243-20-013683-index.htm |
| 2020-06-28 | DEVAL L PATRICK | Director | Buy | 2,400.00 | 2,400.00 | https://www.sec.gov/Archives/edgar/data/1629137/000120919120039333/0001209191-20-039333-index.htm | ||
| 2020-10-01 | DAVID LEE JOHNSON | Chief Commercial Officer | Buy | 4,375.00 | 24,890.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320027383/0000899243-20-027383-index.htm | ||
| 2020-01-31 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 579.00 | 36.68 | 21,237.72 | 2,595.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/0000899243-20-003032-index.htm |
| 2020-02-06 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 3,937.00 | 72.40 | 285,038.80 | 2,595.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003859/0000899243-20-003859-index.htm |
| 2020-02-10 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 625.00 | 70.48 | 44,050.00 | 2,595.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003859/0000899243-20-003859-index.htm |
| 2020-02-18 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 1,313.00 | 69.71 | 91,529.23 | 2,595.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320005350/0000899243-20-005350-index.htm |
| 2020-03-05 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 1,138.00 | 65.30 | 74,311.40 | 2,595.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320007676/0000899243-20-007676-index.htm |
| 2020-03-09 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 938.00 | 59.90 | 56,186.20 | 2,595.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320007676/0000899243-20-007676-index.htm |
| 2020-07-31 | Eric Fink | Chief Human Resources Officer | Buy | 263.00 | 55.47 | 14,588.61 | 263.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021325/0000899243-20-021325-index.htm |
| 2020-05-12 | MARK L PERRY | Director | Sell | 1,295.00 | 79.17 | 102,521.65 | 26,428.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013017/0000899243-20-013017-index.htm |
| 2020-01-31 | BRIAN EDWIN CATHERS | Chief Scientific Officer | Buy | 273.00 | 41.17 | 11,239.41 | 273.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003040/0000899243-20-003040-index.htm |
| 2020-05-12 | MARK L PERRY | Director | Sell | 34,698.00 | 78.65 | 2,728,931.77 | 27,723.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013017/0000899243-20-013017-index.htm |
| 2020-01-27 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 781.00 | 27.90 | 21,789.90 | 2,797.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320002292/0000899243-20-002292-index.htm |
| 2020-05-26 | Lesley Ann Calhoun | Officer | Buy | 2,700.00 | 29.75 | 80,325.00 | 2,854.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320014410/0000899243-20-014410-index.htm |
| 2019-08-01 | Jeffrey S Farrow | Chief Financial Officer | Buy | 9,062.00 | 29,699.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021017/0000899243-19-021017-index.htm | ||
| 2019-11-25 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 298.00 | 19.89 | 5,927.22 | 298.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/0000899243-19-028243-index.htm |
| 2019-12-11 | Philip A. Pizzo | Director | Buy | 15,000.00 | 28.45 | 426,750.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029172/0000899243-19-029172-index.htm |
| 2020-07-13 | Jeffrey S Farrow | Chief Financial Officer | Sell | 15,208.00 | 75.00 | 1,140,600.00 | 3,048.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320019186/0000899243-20-019186-index.htm |
| 2019-11-25 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 312.00 | 12.95 | 4,040.40 | 312.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/0000899243-19-028243-index.htm |
| 2020-06-17 | MARK L PERRY | Director | Buy | 4,800.00 | 31,228.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017318/0000899243-20-017318-index.htm | ||
| 2019-12-13 | Jeffrey S Farrow | Chief Financial Officer | Buy | 5,000.00 | 31,278.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029493/0000899243-19-029493-index.htm | ||
| 2019-11-15 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 313.00 | 12.95 | 4,053.35 | 313.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/0000899243-19-027545-index.htm |
| 2020-06-19 | Dawn Svoronos | Director | Sell | 1,663.00 | 63.69 | 105,913.31 | 3,137.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017315/0000899243-20-017315-index.htm |
| 2020-03-13 | Willie L. Jr. Brown | Director | Buy | 10,000.00 | 52.37 | 523,700.00 | 31,428.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320008652/0000899243-20-008652-index.htm |
| 2020-05-11 | Lesley Ann Calhoun | Officer | Sell | 381.00 | 77.05 | 29,355.75 | 3,146.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013018/0000899243-20-013018-index.htm |
| 2020-02-10 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 625.00 | 12.95 | 8,093.75 | 3,220.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003859/0000899243-20-003859-index.htm |
| 2020-08-01 | Eric Fink | Chief Human Resources Officer | Buy | 3,020.00 | 3,283.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021325/0000899243-20-021325-index.htm | ||
| 2019-11-14 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 329.00 | 20.00 | 6,580.00 | 329.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/0000899243-19-027545-index.htm |
| 2019-11-25 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 3,515.00 | 27.90 | 98,068.50 | 3,515.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/0000899243-19-028243-index.htm |
| 2020-03-09 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 938.00 | 19.89 | 18,656.82 | 3,533.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320007676/0000899243-20-007676-index.htm |
| 2020-06-17 | Willie L. Jr. Brown | Director | Buy | 4,800.00 | 36,228.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017307/0000899243-20-017307-index.htm | ||
| 2020-03-01 | Lesley Ann Calhoun | Officer | Buy | 300.00 | 3,631.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320007087/0000899243-20-007087-index.htm | ||
| 2019-09-01 | Lesley Ann Calhoun | Officer | Buy | 300.00 | 3,756.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319022728/0000899243-19-022728-index.htm | ||
| 2020-02-01 | Jeffrey S Farrow | Chief Financial Officer | Buy | 9,063.00 | 37,862.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320002967/0000899243-20-002967-index.htm | ||
| 2020-02-18 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 1,313.00 | 26.90 | 35,319.70 | 3,908.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320005350/0000899243-20-005350-index.htm |
| 2019-12-13 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 4,000.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319029487/0000899243-19-029487-index.htm | ||
| 2020-05-12 | MARK L PERRY | Director | Buy | 15,000.00 | 20.00 | 300,000.00 | 41,428.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013017/0000899243-20-013017-index.htm |
| 2020-03-01 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 1,750.00 | 4,345.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320007085/0000899243-20-007085-index.htm | ||
| 2019-11-25 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 447.00 | 20.00 | 8,940.00 | 447.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/0000899243-19-028243-index.htm |
| 2020-02-01 | Lesley Ann Calhoun | Officer | Buy | 3,063.00 | 4,485.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003048/0000899243-20-003048-index.htm | ||
| 2019-08-01 | Lesley Ann Calhoun | Officer | Buy | 3,062.00 | 4,516.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021013/0000899243-19-021013-index.htm | ||
| 2019-11-25 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 4,594.00 | 26.90 | 123,578.60 | 4,594.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/0000899243-19-028243-index.htm |
| 2020-06-17 | Dawn Svoronos | Director | Buy | 4,800.00 | 4,800.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017315/0000899243-20-017315-index.htm | ||
| 2020-06-17 | GLENN PIERCE | Director | Buy | 4,800.00 | 4,800.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017314/0000899243-20-017314-index.htm | ||
| 2020-06-17 | Philip A. Pizzo | Director | Buy | 4,800.00 | 4,800.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017305/0000899243-20-017305-index.htm | ||
| 2020-06-17 | Scott W Morrison | Director | Buy | 4,800.00 | 4,800.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017317/0000899243-20-017317-index.htm | ||
| 2020-06-17 | WENDY L YARNO | Director | Buy | 4,800.00 | 4,800.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320017308/0000899243-20-017308-index.htm | ||
| 2019-11-15 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 3,516.00 | 27.90 | 98,096.40 | 4,938.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/0000899243-19-027545-index.htm |
| 2020-05-12 | MARK L PERRY | Director | Buy | 8,600.00 | 20.00 | 172,000.00 | 50,028.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013017/0000899243-20-013017-index.htm |
| 2019-11-15 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 118.00 | 20.00 | 2,360.00 | 5,056.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/0000899243-19-027545-index.htm |
| 2020-08-20 | BRIAN EDWIN CATHERS | Chief Scientific Officer | Sell | 2,200.00 | 63.77 | 140,294.00 | 5,244.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320023299/0000899243-20-023299-index.htm |
| 2019-11-15 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 298.00 | 19.89 | 5,927.22 | 5,354.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/0000899243-19-027545-index.htm |
| 2019-10-08 | DEVAL L PATRICK | Director | Buy | 5,357.00 | 3.40 | 18,213.80 | 5,357.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319025423/0000899243-19-025423-index.htm |
| 2020-07-31 | BRIAN EDWIN CATHERS | Chief Scientific Officer | Buy | 290.00 | 41.17 | 11,939.30 | 5,469.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021333/0000899243-20-021333-index.htm |
| 2019-07-31 | DAVID LEE JOHNSON | Chief Commercial Officer | Buy | 311.00 | 36.68 | 11,407.48 | 6,035.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021012/0000899243-19-021012-index.htm |
| 2020-05-12 | MARK L PERRY | Director | Sell | 13,024.00 | 77.71 | 1,012,138.02 | 62,421.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013017/0000899243-20-013017-index.htm |
| 2020-09-01 | Eric Fink | Chief Human Resources Officer | Buy | 6,250.00 | 6,250.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320024184/0000899243-20-024184-index.htm | ||
| 2020-05-12 | MARK L PERRY | Director | Buy | 15,000.00 | 18.85 | 282,750.00 | 65,028.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013017/0000899243-20-013017-index.htm |
| 2020-02-03 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 2,188.00 | 62.81 | 137,428.28 | 6,532.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/0000899243-20-003032-index.htm |
| 2020-02-03 | Joshua Lehrer-Graiwer | Chief Medical Officer | Sell | 1,657.00 | 65.00 | 107,705.00 | 6,532.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/0000899243-20-003032-index.htm |
| 2019-11-18 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 656.00 | 26.90 | 17,646.40 | 656.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027721/0000899243-19-027721-index.htm |
| 2019-11-25 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 656.00 | 26.90 | 17,646.40 | 656.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028243/0000899243-19-028243-index.htm |
| 2019-11-19 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 6,562.00 | 48.44 | 317,863.28 | 6,562.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027721/0000899243-19-027721-index.htm |
| 2019-12-02 | TRICIA BORGA SUVARI | Chief Legal Officer | Sell | 3,434.00 | 66.74 | 229,185.16 | 6,752.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028411/0000899243-19-028411-index.htm |
| 2020-04-20 | TRICIA BORGA SUVARI | Chief Legal Officer | Sell | 4,080.00 | 75.00 | 306,000.00 | 7,441.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320011153/0000899243-20-011153-index.htm |
| 2020-05-12 | MARK L PERRY | Director | Sell | 600.00 | 76.28 | 45,770.52 | 75,445.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013017/0000899243-20-013017-index.htm |
| 2020-05-12 | MARK L PERRY | Director | Sell | 1,350.00 | 75.43 | 101,833.47 | 76,045.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013017/0000899243-20-013017-index.htm |
| 2020-07-31 | TRICIA BORGA SUVARI | Chief Legal Officer | Buy | 248.00 | 36.68 | 9,096.64 | 7,689.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021331/0000899243-20-021331-index.htm |
| 2020-08-01 | TED W LOVE | Officer | Buy | 42,017.00 | 770,650.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021329/0000899243-20-021329-index.htm | ||
| 2020-05-12 | MARK L PERRY | Director | Sell | 2,633.00 | 74.01 | 194,865.17 | 77,395.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013017/0000899243-20-013017-index.htm |
| 2020-03-01 | BRIAN EDWIN CATHERS | Chief Scientific Officer | Buy | 7,500.00 | 7,773.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320007086/0000899243-20-007086-index.htm | ||
| 2020-05-12 | MARK L PERRY | Director | Buy | 15,000.00 | 28.45 | 426,750.00 | 80,028.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320013017/0000899243-20-013017-index.htm |
| 2020-02-03 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 1,657.00 | 59.60 | 98,757.20 | 8,189.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/0000899243-20-003032-index.htm |
| 2020-01-02 | TRICIA BORGA SUVARI | Chief Legal Officer | Sell | 1,308.00 | 79.78 | 104,352.24 | 8,348.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320000363/0000899243-20-000363-index.htm |
| 2020-08-01 | BRIAN EDWIN CATHERS | Chief Scientific Officer | Buy | 3,020.00 | 8,489.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021333/0000899243-20-021333-index.htm | ||
| 2020-02-01 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 6,100.00 | 8,695.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/0000899243-20-003032-index.htm | ||
| 2020-02-03 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 2,188.00 | 48.44 | 105,986.72 | 8,720.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003032/0000899243-20-003032-index.htm |
| 2020-01-31 | TRICIA BORGA SUVARI | Chief Legal Officer | Buy | 401.00 | 36.68 | 14,708.68 | 8,749.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320003025/0000899243-20-003025-index.htm |
| 2019-04-01 | DAVID LEE JOHNSON | Chief Commercial Officer | Buy | 8,750.00 | 8,750.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319009557/0000899243-19-009557-index.htm | ||
| 2019-09-11 | Lesley Ann Calhoun | Officer | Sell | 2,765.00 | 54.36 | 150,296.28 | 887.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319023567/0000899243-19-023567-index.htm |
| 2020-09-01 | BRIAN EDWIN CATHERS | Chief Scientific Officer | Buy | 3,750.00 | 8,994.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320024183/0000899243-20-024183-index.htm | ||
| 2019-08-01 | DAVID LEE JOHNSON | Chief Commercial Officer | Buy | 3,125.00 | 9,160.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319021012/0000899243-19-021012-index.htm | ||
| 2019-12-09 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 937.00 | 19.89 | 18,636.93 | 937.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319028940/0000899243-19-028940-index.htm |
| 2020-08-05 | Eric Fink | Chief Human Resources Officer | Sell | 1,504.00 | 69.32 | 104,255.02 | 950.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924320021756/0000899243-20-021756-index.htm |
| 2019-11-15 | Joshua Lehrer-Graiwer | Chief Medical Officer | Buy | 4,594.00 | 26.90 | 123,578.60 | 9,948.00 | https://www.sec.gov/Archives/edgar/data/1629137/000089924319027545/0000899243-19-027545-index.htm |